Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Lee Roy Morgan"'
Publikováno v:
Anticancer Research. 43:1407-1413
Autor:
Roy S. Weiner, Philip Friedlander, Lee Roy Morgan, M. Bhandari, Marcus L. Ware, Tallat Mahmood
Publikováno v:
Global Journal of Medical Research. :31-33
In 2020 about 89,000 adolescents and young adults (AYA) (ages 15 to 39) were estimated to be diagnosed with cancer in the United States, 23,890 had CNS and spinal nervous system(SNS) involvement—accounting for one twentieth or five percent of the n
Autor:
Lee Roy Morgan, Roy S. Weiner, T. Mahmood, C. Gordon, M. Bhandari, AH Rodgers, ML Ware, Marc Matrana, Thomas M. Cosgriff, Philip Friedlander, J-J Zou
Publikováno v:
Cancer Research. 82:CT158-CT158
Background: 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) is a poly-chlorinated pyridine cholesteryl carbonate that was designed to penetrate the blood brain barrier and be useful as therapy for brain tumors (IND 68,876). A 3-stage me
Autor:
M. Bhandari, Roy S. Weiner, Lee Roy Morgan, Philip Friedlander, Marcus L. Ware, Tallat Mahmood
Publikováno v:
Journal of Cancer Research Updates. 7:75-78
4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) is a poly-chlorinated pyridine carbonate with a MOA via bis -alkylation of DNA @ N 7 -guanine and N 4 -cytosine that has completed adult clinical Phase I and II trials in individuals with
Autor:
Lee Roy Morgan, Roy S. Weiner, Tallat Mahmood, Marcus L. Ware, Andrew H. Rodgers, Manish Bhandari, Philip Friendlander
Publikováno v:
Molecular Cancer Therapeutics. 20:P038-P038
Background: 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) is a poly-chlorinated pyridine cholesteryl carbonate with a MOA via bis-alkylation of DNA @ N7-guanine and N4-cytosine that is currently in Phase II trial in AYA subjects with
Autor:
Marc R. Matrana, Marcus L. Ware, Thomas Cosgriff, Jay J. Zou, Philip Friedlander, Craig Gordon, M. Bhandari, Andrew H. Rodgers, Lee Roy Morgan, Tallat Mahmood, Roy S. Weiner
Publikováno v:
Cancer Research. 81:CT152-CT152
Background: 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) is a poly-chlorinated pyridine cholesteryl carbonate with a MOA via bis-alkylation of DNA @ N7-guanine and N4-cytosine that has completed Phase I and II trials (the latter incl
Autor:
Tallat Mahmood, Lee Roy Morgan, M. Bhandari, R. Kawauchi, S.J. DiBiase, M. Ware, Ali Baghian, Philip Friedlander, K. Harris, Roy S. Weiner, Kiran Devisetty, James Herman
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e716-e717
Autor:
Trevor Rosenlof, Marcus I. Ware, Michael J. Strong, Roy S. Weiner, Lee Roy Morgan, Siddhartha Padmanabha
Publikováno v:
Journal of Neurosurgery: Spine. 23:607-612
The authors describe the case of a patient who initially presented with uterine leiomyosarcoma (LMS) that later metastasized to the spine. The patient was treated at another institution for her primary uterine LMS, undergoing resection followed by ad
Autor:
Tallat Mahmood, Kendra Harris, Marcus L. Ware, Steven J. DiBiase, James Herman, Paul Friedlander, R. Kawauchi, M. Bhandari, Lee Roy Morgan, Ali Baghian, Roy S. Weiner, Kiran Devisetty
Publikováno v:
Cancer Research. 80:CT101-CT101
Purpose: 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) is a poly-chlorinated pyridine cholesteryl carbonate with a MOA via bis-alkylation of DNA @ N7-guanine and N4-cytosine that has completed Phase I/II studies [AACR, #CT129, 2017] i
Autor:
Andrew H. Rodgers, M. Bhandari, Philip Friedlander, Tallat Mahmood, Marcus L. Ware, Lee Roy Morgan, Roy S. Weiner
Publikováno v:
Cancer Research. 80:CT181-CT181
Background: 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) is a poly-chlorinated pyridine cholesteryl carbonate with a MOA via bis-alkylation of DNA @ N7-guanine and N4-cytosine that has completed Phase I and now in Phase II clinical t